A phase III study of the efficacy and safety of a novel iron-based phosphate binder in dialysis patients

Efficacy of PA21 (sucroferric oxyhydroxide), a novel calcium-free polynuclear iron(III)-oxyhydroxide phosphate binder, was compared with that of sevelamer carbonate in an open-label, randomized, active-controlled phase III study. Seven hundred and seven hemo- and peritoneal dialysis patients with hy...

Descripció completa

Guardat en:
Dades bibliogràfiques
Autors principals: Floege, Jürgen, Covic, Adrian C, Ketteler, Markus, Rastogi, Anjay, Chong, Edward M F, Gaillard, Sylvain, Lisk, Laura J, Sprague, Stuart M
Format: Artigo
Idioma:Inglês
Publicat: Nature Publishing Group 2014
Matèries:
Clinical Trial
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC4150998/
https://ncbi.nlm.nih.gov/pubmed/24646861
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/ki.2014.58
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars